Bacillus pilifarmis antigens were demonstrated in smear preparations from infected mouse livers by direct immunofluorescence technique. Mouse serum antibodies against B. pilifarmis were demonstrated by indirect immunofluorescence technique. The test was employed quantitatively both on sera from experimentally infected mice and on sera from clinically healthy mice from colonies infected with B. pilifarmis, and could be used for the quantitative demonstration of antibodies in sera from a stock of rabbits with Tyzzer's disease. It was found very useful for the detection of subclinical infection.
Tyzzer's disease is an important infectious disease in laboratory mice, and there is reason to believe that subclinical disease occurs. Several publications during the last 10-15 years indicate that Bacillus pillformis infections are widely distributed geographically aGwell as among animal species (Fries, 1977) . It is obviously desirable to make a closer study of the disease and of the distribution and frequency of subclinical infections in colonies of laboratory animals. It would be especially desirable to develop serodiagnostic methods of detection, as diagnosis based on provocation and identification of the bacterium is laborious and sometimes unspecific. Fujiwara (1967) demonstrated antibodies in mouse immune serum against a B. pillformis antigen by the complement fixation (CF) test and by immunodiffusion. He subsequently found the CF test useful for testing sera from retired breeder mice, but not for testing sera from weanlings (Fujiwara, 1971) .
For diagnosis the CF test and the counterimmunoelectrophoresis (CIEP) test (see p. 70) are not sensitive enough to detect antibodies present in sera from naturally infected mice until after a booster injection.
Immunofluorescence has been used for detection of B. piliformis in experimentally-infected mice (Fujiwara, Kurash ina, Matsunuma & Takahashi, 1968; Ondera & Fujiwara, 1970 Savage & Lewis, 1972) and for demonstration of antibodies (Fujiwara, Takahashi, Kurashina & Matsunuma, 1969; Fujiwara, Yamada, Ogawa & Oshima, 1971) . The use of the immunofluorescence antibody (FA) technique for the diagnosis of subclinically B. piliformis infections has not been reported.
Resume of previously unpublished studies not involving immunofluorescence Comparison between different immunization procedures with homogenates from infected livers showed that satisfactory antibody production was obtained in mice by giving 5 injections of freshlyprepared homogenates of infected livers during 7 weeks. In using formalin-treated liver homogenates, antibodies were found against the antigen in sera from the controls: as formalin-treated material offers no special advantage it should not be used.
Antibodies were demonstrated in sera from immunized mice by immunodiffusion in agar gel, reversed single radial immunodiffusion, qualitative and quantitative immunoelectrophoresis, counter immunoelectrophoresis (CIEP), passive cutaneous anaphylaxis, and complement fixation. Conclusions based on the results of these tests are given below.
The complement-fixation test has certain limitations: even in the microsystem the test requires relatively large quantities of serum, which makes testing of serial samples from individual mice difficult.
Testing by passive cutaneous anaphylaxis is very sensitive and may in some cases be particularly useful because it is the only in vivo reaction among these tests. The principal drawback is the need for relatively large quantities of serum and, with mice, the difficulty of administering intradermal injections owing to their small size and thin skin. The thin skin makes the intradermal technique less accurate than with, for example, guinea-pigs.
The CIEP test was found to be useful and only requires 2-5 III serum. The apparatus required is simple. Compared with testing by immunodiffusion the results in CIEP test are rapidly obtained and' easy to read. The CIEP test is also more sensitive.
Reversed radial immunodiffusion and reversed rocket immunoelectrophoresis are useful for the quantitation of antibodies. Care must be taken when mixing antigen with gel, because the setting temperature of the agar gel is only a few degrees lower than the temperature where heat degradation of the antigen occurs.
Antibodies were demonstrated from only a few spontaneously-and experimentally-infected mice. After treating mice previously inoculated with B. pilifarmis with a booster injection of infected-liver homogenates, or with antigen from infected liver, antibodies were found in sera from all the mice. This procedure was used diagnostically: sera from 99 clinically healthy mice from a stock infected with B. pilifarmis were tested by CIEP before injection of antigen. After antigen treatment the sera were tested by CIEP as well as by reversed rocket immunoelectrophoresis.
About 4 % were positive before and 30 % after the booster injection.
Materials and methods Animals
For serial passages and for the preparation of infective material conventional mice from a stock originating from Ssc: CH were used. For the experiments, specifiedpathogen-free NMRT/Bom mice were employed from a breeding colony routinely checked for the absence of B. piliformis. The animals were housed in conventional animal rooms at 22 ± 2°C. The mice were housed in polycarbonate cages with sawdust as bedding, and given a pelle ted diet (Rostock Mixture, Korn-og Foderstofkompagniet AIS, Liidersvej, DK-2100 Copenhagen) and bottled tap water ad libitum.
Conventionally-bred Ssc: CPR rabbits were employed for production of antibodies. They were housed in metal cages with floors of wire mesh in rooms at the same temperature as the mice, and were given a pelleted diet (Boserup, DK-4640 Fakse, Denmark), 140 g per day, and tap water ad libitum.
Infective materials B. piliformis was obtained from a case of Tyzzer's disease in mice. The organism was maintained by mouse passages and by storing infected livers in liquid nitrogen (Fries, 1977) .
Immunization of mice 6-week-old mice were given infectious liver homogenate (10% wlv in phosphate buffered saline-PBS-pH 7'2) 0·1 ml subcutaneously on day 1, 0·2 ml subcutaneously on days 8 and 15, and 0,5 ml intraperitoneally on days 42 and 49. Blood samples were collected 10-12 days later from the orbital venous plexus. Mice serving as controls were treated in the same manner with the liver homogenates from non-infected mice.
Production of antibodies
Rabbits were injected subcutaneously with 0·75 ml of 20% wlv homogenate from infected mouse liver in 0·75 ml of Freund's incomplete adjuvant. On day 42 after the injection the animals were injected with 1 ml of infected liver homogenate intraperitoneally. Blood samples Fries were obtained from the marginal vein of the ear 10 days later and subsequently every 6th week after intraperitoneal injection of 1 ml of infective liver homogenate 8-10 days before each bleeding.
Mouse immunoglobulin was prepared by precipitation with ammonium sulphate 'as described below (p. 70). To produce antibodies rabbits were injected intradermally on days 1, 15,29 and 43 with 1 mg of the globulin dissolved in 0·1 ml saline in Freund's incomplete adjuvant. Blood samples were collected on day 54. 10 days before further blood sampling the rabbits were given a 1 mg booster injection.
Absorption of antibodies to mouse liver tissue in rabbit immune serum 1 part liver homogenate (50% w/v) from non-infected mice in PBS, pH 7,2, was added to 2 parts of rabbit immune serum. After incubation at 37°C for 30 min the mixture was placed at room temperature for 30 min and then stored overnight at 4°C. The preparation was centrifuged the next day by 10 000 g for 30 min. The resulting supernatant was tested for precipitating antibodies against an antigen prepared of non-infected mouse liver by double diffusion in agar gel and by immunoelec t rophoresis.
Conjugation with fluorescei~lisothiocyanute (FITC) .
After absorption the antlserum was processed 10 a manner similar to that described by Nairn (1969) and Holborow & Johnson (1967) . The globulin was precipitated by adding an equal volume of cold saturated ammonium sulphate solution to 2 ml serum. After incubation at 37°C for 30 min and centrifugation at 2500 g the precipitate was redissolved in distilled water. The p;ocedure was repeated and the globulin solution was dialyzed against PBS for 18 h at 4°C with change of the buffer solution after 4 h dialysis.
To the globulin solution was added 7 ml of 0·15 M saline and 1 ml of 0,5 M carbonate bicarbonate buffer pH 9,0. After cooling to 4°C 5 mg FITC (Sigma Chemical Compo St Louis, USA) was added while stirring during 15 min. The stirring was continued overnight at 4°C. The conjugated preparation was dialyzed against PBS as described before for the immunoglobulin.
Surplus FITC was removed by gel filtration through a Sephadex G-25 column which had been equilibrated with PBS. The conjugate was stored at -20°C. Normal rabbit serum was conjugated in the same manner and was used as control.
Demonstration of B. pili/ormis
. Smear preparations of infected mouse liver were air dried and fixed in acetone for 10 min or 96% ethanol for 20 min. The preparations were washed in PBS and stained with a drop of 1/10 dilution of the FITC conjugate for 30 min at 37°C in a moist cham~er. After washing for 5 min in PBS 3 times, the preparatIons w~re mounted with glycerol and PBS (l :1), and cover slips applied. A FlTC labelled rabbit anti-B. piliformis serum University) was used in parallel m some exammatlOns. This serum had been obtained from rabbits immunized with material infected with a B. piliformis strain originating from rabbits with naturally-occurring Tyzzer's disease. Preparation of noninfected livers, cultures of Bacillus spp., Escherichia coli, Staphylococcus aureus, Listeria monocytogenes and Clostridium perfringens served as controls.
Demonstratioll of B. piliformis antibodies by the FA technique 8 small drops of glycerol were placed on ether-and ethanol-cleaned glass slides (76 x 26 mm), which were then coated with PTFE spray (Plastibrand, Rudolf Brand, 698 Wertheim, Postfach 310, W. Germany) in a fume cupboard. The glycerol drops were removed by rinsing with distilled water after .15 min, and the slides dried. On the uncoated areas of the slides (where the glycerol had been) B. piliformis-infected mouse-liver homogenate in PBS (I % w/v) was applied. The complete area of the circles was covered, but only with a thin layer. The preparations were air dried and fixed in acetone for 10 min. The test was carried out by covering each antigen circle with a drop of the serum dilution to be tested. The slides were then incubated in a moist chamber at 37°C for 30 min and were washed 3 times in PBS. Excess buffer was removed and a drop of the conjugate was placed on the circles. After incubation at 37°C for 30 min and 3 times washing in PBS, the preparations were mounted with glycerol and PBS (l :1) and a cover slip applied.
For the demonstration of antibodies in mouse sera the FlTC-conjugated rabbit anti-mouse globulin in dilution 1 :20 was used, and for the demonstration of antibodies in rabbit sera a FlTC-conjugated swine antirabbit serum IgG (Dako-immunoglobulins, Dakopatts A/S, DK-2000 Copenhagen) diluted 1 :30.
Positive and negative sera were included in each test. The specificity of the test was further controlled by use of homogenates of noninfected livers and by employing a FlTC-conjugated normal rabbit serum.
The sera were tested in dilutions 1 :30 for the mouse sera and 1 :10 for the rabbit sera. in infected preparations both with conjugated serum prepared in the laboratory and serum from Dr Gleiser. Incubation with unlabelled rabbit immune serum before the incubation with the FITC-labelled globulin blocked the fluorescence. The organism showed no fluorescence after incubation with FITC-labelled normal rabbit serum. None of the control bacteria showed fluorescence after staining with the FlTC conjugate. In Fig. 1 the fluorescence of B. pili/armis is demonstrated in mouse liver homogenate by indirect immunofluorescence using a positive rabbit serum. Demonstration of antibodies to B. piliformis in sera from mice. Sera from mice immun~zed with homogenates from infected mouse livers were tested for antibodies by the FA technique (Table 1) . Antibodies were found in all the sera with titres of 240-3840. Of the 20 sera, 15 had titres of;> 2880. Sera from experimentally infected mice. 4-week-old mice were inoculated intravenously with infected liver homogenate, and sera obtained from the survivors 7 days later. By the FA technique antibodies were found in all the sera, with titres of 120-960 (Table 1) . No antibodies were demonstrated in sera drawn from the mice before the inoculation, and 
Results

Investigations on mice
Investigation on rabbits
An institute in Copenhagen imported lO-week-old disease-free New Zealand White rabbits from Great Britain. They were placed in autodaved cages in a disinfected and air-conditioned animal room. No rabbits had been housed in the institute for the previous 4 months. The animals were fed with pellets (Boserup, DK-4640 Fakse, Denmark), and tap water was freely available. Diarrhoea was observed 2 weeks later and some rabbits died. At necropsy typhlocolitis and liver necrosis were found. B. pili/armis was demonstrated microscopically in the liver.
On testing 64 sera from the surviving rabbits 4 weeks after arrival from Great Britain, 46 reacted positively, 70% with titres ;;:, 160 (Table 2) .
Test sera from B. pili/armis infected mouse colonies. Mouse sera were collected from 2 conventional colonies where B. pili/armis occurs. Sera from Ssc: AH mice from colony A were previously tested by counterimmunoelectrophoresis and reversed rocket electrophoresis. The sera from colony B were drawn from mice in the breeding unit. The mice were ]0-31 weeks old. Antibodies were found in 35 out of 97 sera from colony A (36%), and 341 out of 413 sera from colony B (83 %). Titre in colony A ranged from 30 to 1920 (Table 1) . none were found in control sera from 10 mice inoculated with liver homogenate from noninfected mice.
No. positive/no. tested of 2880 or more was found. Antibodies were demonstrated in experimentally-infected 5-week-old mice as early as 7 days after the inoculation (titres 120-960).
In a previous study sera from 99 mice from colony A were tested by CIEP before and after a booster injection of antigen prepared from infected mouse liver. Before the injection 4 and after it 32 of the sera reacted positively. By testing the sera drawn before the booster injection by the FA technique 35 out of the 97 sera reacted positively with titres of 30-1920. The 4 mice reacting positively by CIEP before the booster also reacted positively by the FA technique. 30 of the 32 sera reacting positively by CIEP after the booster also reacted positively by the FA technique.
Tyzzer's disease in rabbits was described in ] 965 by Allen, Ganaway, Moore & Kinard. Since then it has been reported in other rabbit colonies in U.S.A. (Cutlip, Amtower, Beall & Matthews, 1971; Van Kruiningen & Blodgett, 1971; Savage & Lewis, 1972) , but the disease appears not to have been reported previously from outside U.S.A. In this study, antibodies to B. pili/armis were demonstrated in 46 of 64 sera tested, exemplifying the usefulness of the FA technique for testing rabbits.
The infection in rabbits had previously been demonstrated microscopically at the Department of Pathology when B. pili/armis was found in the liver (unpublished observation, 197] ). Subsequently, microscopic re-examination of rabbit liver material stored in the Department detected B. pili/armis in several cases. These livers were from rabbits in Discussion which typhlocolitis was diagnosed in 1957-1959. The diagnosis of Tyzzer's disease is usually based
The present observations show that B. pili/armis on the microscopic demonstration of B. pili/armis. infections exist in rabbit colonies in Denmark, and In the present work B. pili/armis antigens have have in fact been present for several years. been detected in tissues from naturally-as well as It seems reasonable to assume that the rabbits from experimentally-infected mice by the immuno-imported from Great Britain were infected with the fluorescence technique. Specific fluorescence was organism at the time of arrival in Denmark. The found by use of 2 different conjugated globulins.
animals were maintained at the institute under The technique has not previously been used for the high standards of management. The possibility of demonstration of B. pili/armis in naturally-infected contamination through unautoc1aved diet exists but mice.
is not probable, and other potential sources of The CF test (Fujiwara, 1971 ) and CIEP can be contamination seem not to exist. used for the demonstration of antibodies to B.
In conclusion, these studies have shown that the pili/armis, but naturally-infected mice must be given FA technique is very useful for detecting antibodies a booster injection of antigen prior to sampling and for the quantitative evaluation of antibodies in before antibodies can be detected in the sera. The sera from mice and rabbits. The technique thus FA technique was found to be more sensitive: in makes it easy to diagnose B. pili/armis infection 175% of the sera from the immunized mice a titre in animals. 
